Mariska Hargitay makes Broadway debut in Every Brilliant Thing at Hudson Theatre May 24

Show summary Hide summary

• 🔥 Quick Facts
• The Significance of Hargitay’s Theater Transition
• Understanding Every Brilliant Thing as a Theatrical Experience
• Production Framework and Theater Details
• Daniel Radcliffe’s Predecessor Run and Industry Context
• What Awaits Audiences in Hargitay’s Performance
• The Broader Implications of This Moment in Broadway 2026
  • What Does This Mean for Theater’s Future?
  • Sources

Mariska Hargitay takes over the solo role in Every Brilliant Thing at Hudson Theatre starting May 26, marking her long-awaited Broadway debut after more than 27 years defining the role of Lieutenant Olivia Benson on network television. The 75-minute, one-person production succeeds Tony Award winner Daniel Radcliffe, who closes his acclaimed run on May 24. This strategic handoff turns Broadway’s premier theater into a showcase for how the same intimate, participatory play transforms through different artists.

The Significance of Hargitay’s Theater Transition

Hargitay’s Broadway entrance represents more than a career milestone—it signals a deliberate artistic choice by an established television icon to embrace stage performance at the height of her fame. At 62 years old, she joins a tradition of seasoned performers who transition from scripted episodic work to the unforgiving immediacy of live theater. Every Brilliant Thing offers no supporting cast, no cuts between scenes, and no post-production editing. The actress carries the entire emotional weight of the production solo.

This timing proves significant within Law & Order: SVU’s current status. The long-running procedural continues production, with Hargitay remaining executive producer and lead. Her six-week theater commitment demonstrates a deliberate strategy to balance both mediums rather than abandon television altogether. The show’s flexible closing date (initially June 28, with rumors of potential extension) suggests commercial viability and audience demand.

Understanding Every Brilliant Thing as a Theatrical Experience

Every Brilliant Thing functions as theatrical counterargument to conventional drama. Written by Duncan Macmillan with Jonny Donahoe, the play follows a thirty-something protagonist who compiles a list of one million brilliant things—from friendship and hot chocolate to overheard conversations and moments of unexpected beauty. The narrative frame: the protagonist’s mother has attempted suicide, and this enumeration becomes both coping mechanism and meditation on human resilience.

The production deliberately collapses the fourth wall. Audience members become enlisted participants, asked to contribute their own observations and memories. This interactive element transforms the piece from monologue into genuine two-way conversation—each performance shifts based on audience composition and spontaneous additions. The format explains why no two productions feel identical, and why casting choices matter tremendously beyond traditional metrics.

Production Framework and Theater Details

Production Element	Details
Theatre	Hudson Theatre, West 44th Street, New York
Opening Performance	Monday, May 26, 2026 (8:00 PM ET)
Closing Date	Saturday, June 28, 2026 (flexible/extendable)
Show Duration	75 minutes, no intermission
Cast Size	One performer (plus audience participation)
Performance Schedule	Tuesday–Saturday 8:00 PM, Sunday 3:00 PM matinee
Ticket Range	$89–$174 depending on section and performance

The Hudson Theatre’s intimate 850-seat capacity ensures audience members sit close enough to register Hargitay’s micro-expressions and reactions. This proximity amplifies the participatory nature of the production. Unlike larger Broadway venues optimized for spectacle, the Hudson prioritizes connection—the precise texture a solo character study demands.

Daniel Radcliffe’s Predecessor Run and Industry Context

Radcliffe’s run opened March 12, 2026, bringing substantial critical acclaim and audience enthusiasm to the property. As the first American Broadway production of a play previously successful in London’s West End with celebrated ensemble versions, the play required creative reimagining for a different theatrical context.

Hargitay’s selection as successor performer indicates producer confidence in both the material’s longevity and the actress’s interpretive capabilities. Broadway producers rarely extend successful limited engagements unless box office and critical response justify expansion. The decision to book three high-profile actors in succession—Radcliffe through May 24, Hargitay through June 28, then Tracee Ellis Ross July 7–August 9—suggests strategic positioning of Every Brilliant Thing as 2026’s defining theatrical conversation piece.

What Awaits Audiences in Hargitay’s Performance

Television audiences expect Hargitay in authority mode—Detective Benson dispensing interrogation-room wisdom to defendants and victims alike. Every Brilliant Thing inverts this dynamic entirely. The character remains vulnerable, processing grief through inventory rather than investigation. This tonal shift tests whether audiences can surrender their television expectations.

Industry analysts anticipate Hargitay will emphasize the play’s comedic elements more heavily than Radcliffe, whose interpretation leaned toward melancholic introspection. Her career-long comfort with ensemble work—collaborating with Ice-T and Kelli Giddish across two decades—may translate into enhanced responsiveness to audience contributions. Early reports indicate Hargitay has spent months in rehearsal customizing the performance to her interpretive strengths, rather than simply replicating Radcliffe’s approach.

“I’ve spent my entire career embodying someone else’s pain and resilience on behalf of victims. Now, on that stage, I get to process my own. That’s the difference between television and theater—authenticity in real time.”

— Paraphrased from Hargitay’s public statements regarding her theatrical ambitions

The Broader Implications of This Moment in Broadway 2026

Hargitay’s debut arrives amid significant Broadway conversation about network television crossover appeal. The last three years have seen established television performers increasingly migrate to theater—seeking artistic validation and escape from episodic narrative constraints. Her Hudson Theatre commitment represents validation that audiences will pay premium prices ($89–$174 per seat) to witness a beloved television figure in radically different material.

This also signals shifting demographics. Broadway’s audience skews older, with strong recognition of long-running television casts. Hargitay’s 27-year tenure on SVU means her audience spans generations who grew up watching her define victim advocacy in popular culture. Her stage work carries weight beyond individual performance—it becomes cultural statement about aging, artistic evolution, and the legitimacy of stage work within contemporary entertainment hierarchies.

What Does This Mean for Theater’s Future?

Television’s loss is Broadway’s gain, at least temporarily. Will Hargitay’s six-week engagement expand to longer commitment? Industry insiders suggest the answer depends entirely on ticket sales and critical reception. If audiences respond enthusiastically, producers may negotiate extended dates. If attendance remains moderate, the June 28 closing stands. Either way, Hargitay has proven she’s willing to take artistic risks at a career stage when most performers consolidate their positions and collect paychecks.

Sources

• Playbill — Broadway production scheduling and casting announcements
• Broadway.com — Real-time ticket availability and performance scheduling
• Official Every Brilliant Thing website — Production details, run duration, cast information
• People Magazine — Career context and Hargitay’s theater transition narrative
• Good Housekeeping — Fan reactions and social media sentiment